Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Revenue
March 20, 2013 at 04:13 AM EDT
Below are the top diagnostic substances stocks on the NASDAQ in terms of revenue. The trailing-twelve-month revenue at IDEXX Laboratories (NASDAQ: IDXX ) is $1.29 billion. IDEXX had $223.99 million in total cash for the latest quarter. The trailing-twelve-month revenue at Meridian Bioscience (NASDAQ: VIVO ) is $178.82 million. Meridian
